<DOC>
	<DOCNO>NCT00708578</DOCNO>
	<brief_summary>Primary objective : To find optimal regimen OHA ( oral hypoglycaemic agent ) combination insulin glargine ( metformin , glimepiride metformin+glimepiride ) measure HbA1c level Secondary objective : To compare incidence hypoglycemia treatment group</brief_summary>
	<brief_title>Optimal Oral Hypoglycaemic Agents ( OHA ) Combination With Insulin Glargine ( Sulfonylurea vs. Metformin )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 2 diabetes least 6 month Treated maximal , tolerable dose metformin ( ≥ 1000mg/day ) sulfonylurea ( glimepiride≥ 4 mg/day equivalent dose SU ) least 3 month prior screen visit 7.0 &lt; HbA1c &lt; 11 % Fasting serum Cpeptide &gt; 0.33 nmol/L BMI &lt; 30 kg/m² Patients willing monitor BG use SMBG Type 1 Diabetes Clinical evidence active liver disease , serum ALT 3 time upper limit normal range Serum creatinine : ≥ 1.5 mg/dl male , ≥ 1.4 mg/dl female Active proliferative diabetic retinopathy , define application photocoagulation surgery , 6 month study entry unstable ( rapidly progress ) retinopathy may require photocoagulation surgery study ( optic fundus examination perform 2 year prior study entry ) History alcohol substance abuse Pregnancy use contraceptive childbearing aged woman Breast feed woman History hypersensitivity study drug drug similar chemical structure Treatment medication include corticosteroid herbal medicine affect blood glucose level within 3 month prior study entry except metformin sulfonylurea . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>